NCT00937651 - Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Essential Hypertension

Interventions

DRUG

Placebo

DRUG

Fimasartan (BR-A-657•K) 20 mg

Fimasartan 20 mg, 1 tablet + placebo, 2 tablets

DRUG

Fimasartan (BR-A-657•K) 60 mg

Fimasartan 20 mg, 1 tablet + 40 mg, 1 tablet + placebo 1 tablet

DRUG

Fimasartan (BR-A-657•K) 180 mg

Fimasartan 20 mg, 1 tablet + 80 mg, 1 tablet + 80 mg 1 tablet